company background image
SHC logo

Sotera Health NasdaqGS:SHC Stock Report

Last Price

US$11.28

Market Cap

US$3.2b

7D

-0.5%

1Y

-32.6%

Updated

14 Apr, 2024

Data

Company Financials +

Sotera Health Company

NasdaqGS:SHC Stock Report

Market Cap: US$3.2b

Sotera Health Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sotera Health
Historical stock prices
Current Share PriceUS$11.28
52 Week HighUS$19.40
52 Week LowUS$10.74
Beta2.11
1 Month Change-22.31%
3 Month Change-26.47%
1 Year Change-32.58%
3 Year Change-57.09%
5 Year Changen/a
Change since IPO-55.06%

Recent News & Updates

The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Mar 21
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Mar 01
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Recent updates

The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Mar 21
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Mar 01
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount

Feb 08

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Feb 06
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Dec 28
Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

Dec 11
Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sep 10
An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jun 05
Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Feb 13
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Nov 24
Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Sotera Health plunges 20% after jury awards $363M against its Sterigenics unit

Sep 19

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sep 08
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M

Aug 04

Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?

May 09
Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?

Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)

Mar 16
Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?

Jan 19
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?

A Look At The Fair Value Of Sotera Health Company (NASDAQ:SHC)

Sep 24
A Look At The Fair Value Of Sotera Health Company (NASDAQ:SHC)

Earnings Beat: Sotera Health Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 15
Earnings Beat: Sotera Health Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Shareholder Returns

SHCUS Life SciencesUS Market
7D-0.5%-2.4%-1.7%
1Y-32.6%-4.0%22.9%

Return vs Industry: SHC underperformed the US Life Sciences industry which returned -4% over the past year.

Return vs Market: SHC underperformed the US Market which returned 22.9% over the past year.

Price Volatility

Is SHC's price volatile compared to industry and market?
SHC volatility
SHC Average Weekly Movement7.1%
Life Sciences Industry Average Movement7.1%
Market Average Movement6.1%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: SHC's share price has been volatile over the past 3 months.

Volatility Over Time: SHC's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20153,000Michael Petrassoterahealth.com

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Sotera Health Company Fundamentals Summary

How do Sotera Health's earnings and revenue compare to its market cap?
SHC fundamental statistics
Market capUS$3.19b
Earnings (TTM)US$51.09m
Revenue (TTM)US$1.05b

62.5x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SHC income statement (TTM)
RevenueUS$1.05b
Cost of RevenueUS$472.13m
Gross ProfitUS$577.16m
Other ExpensesUS$526.07m
EarningsUS$51.09m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 02, 2024

Earnings per share (EPS)0.18
Gross Margin55.00%
Net Profit Margin4.87%
Debt/Equity Ratio502.2%

How did SHC perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.